Literature DB >> 21245439

Time-kill activity of the streptogramin NXL 103 against Gram-positive and -negative bacteria.

Glenn A Pankuch1, Gengrong Lin, Catherine Clark, Peter C Appelbaum.   

Abstract

Against 33 Gram-positive and -negative bacteria, NXL 103 MICs were 0.03 to 1 μg/ml. NXL 103 was bactericidal by 12 h at 2 × MIC against all 5 pneumococci and at 2 × MIC after 24 h against all 5 group A and B β-hemolytic streptococci. NXL 103 was bactericidal against all 8 Haemophilus influenzae strains at 2 × MIC and all 5 Moraxella catarrhalis strains at 4 × MIC after 24 h but was mainly bacteriostatic against 5 methicillin-resistant Staphylococcus aureus strains. After the exposure of one strain of each species to NXL 103 for 10 daily subcultures, the MICs remained within ± 1 dilution.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21245439      PMCID: PMC3067140          DOI: 10.1128/AAC.01159-10

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  17 in total

1.  Reversion of the glycopeptide resistance phenotype in Staphylococcus aureus clinical isolates.

Authors:  S Boyle-Vavra; S K Berke; J C Lee; R S Daum
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

2.  In vitro activity of an oral streptogramin antimicrobial, XRP2868, against gram-positive bacteria.

Authors:  G M Eliopoulos; M J Ferraro; C B Wennersten; R C Moellering
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

3.  Activity of a new oral streptogramin, XRP2868, against gram-positive cocci harboring various mechanisms of resistance to streptogramins.

Authors:  Michel Dupuis; Roland Leclercq
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

4.  In vitro activity of CEM-101 against Streptococcus pneumoniae and Streptococcus pyogenes with defined macrolide resistance mechanisms.

Authors:  Pamela McGhee; Catherine Clark; Klaudia M Kosowska-Shick; Kensuke Nagai; Bonifacio Dewasse; Linda Beachel; Peter C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  2009-11-02       Impact factor: 5.191

5.  Antistaphylococcal activity of DX-619, a new des-F(6)-quinolone, compared to those of other agents.

Authors:  Tatiana Bogdanovich; Duygu Esel; Linda M Kelly; Bülent Bozdogan; Kim Credito; Gengrong Lin; Kathy Smith; Lois M Ednie; Dianne B Hoellman; Peter C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

6.  A clone of methicillin-resistant Staphylococcus aureus among professional football players.

Authors:  Sophia V Kazakova; Jeffrey C Hageman; Matthew Matava; Arjun Srinivasan; Larry Phelan; Bernard Garfinkel; Thomas Boo; Sigrid McAllister; Jim Anderson; Bette Jensen; Doug Dodson; David Lonsway; Linda K McDougal; Matthew Arduino; Victoria J Fraser; George Killgore; Fred C Tenover; Sara Cody; Daniel B Jernigan
Journal:  N Engl J Med       Date:  2005-02-03       Impact factor: 91.245

7.  The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents.

Authors:  Michael R Jacobs; David Felmingham; Peter C Appelbaum; Reuben N Grüneberg
Journal:  J Antimicrob Chemother       Date:  2003-07-15       Impact factor: 5.790

8.  Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection.

Authors:  Timothy S Naimi; Kathleen H LeDell; Kathryn Como-Sabetti; Stephanie M Borchardt; David J Boxrud; Jerome Etienne; Susan K Johnson; Francois Vandenesch; Scott Fridkin; Carol O'Boyle; Richard N Danila; Ruth Lynfield
Journal:  JAMA       Date:  2003-12-10       Impact factor: 56.272

9.  Activities of a new oral streptogramin, XRP 2868, compared to those of other agents against Streptococcus pneumoniae and haemophilus species.

Authors:  Glenn A Pankuch; Linda M Kelly; Gengrong Lin; Andre Bryskier; Catherine Couturier; Michael R Jacobs; Peter C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  2003-10       Impact factor: 5.191

10.  Susceptibility trends of haemophilus influenzae and Moraxella catarrhalis against orally administered antimicrobial agents: five-year report from the SENTRY Antimicrobial Surveillance Program.

Authors:  D M Johnson; H S Sader; T R Fritsche; D J Biedenbach; Ronald N Jones
Journal:  Diagn Microbiol Infect Dis       Date:  2003-09       Impact factor: 2.803

View more
  3 in total

1.  Modular Chemical Synthesis of Streptogramin and Lankacidin Antibiotics.

Authors:  Lingchao Cai; Ian B Seiple; Qi Li
Journal:  Acc Chem Res       Date:  2021-04-01       Impact factor: 22.384

2.  Modular synthesis of streptogramin antibiotics.

Authors:  Qi Li; Ian B Seiple
Journal:  Synlett       Date:  2020-10-20       Impact factor: 2.454

Review 3.  The Mechanisms of Action of Ribosome-Targeting Peptide Antibiotics.

Authors:  Yury S Polikanov; Nikolay A Aleksashin; Bertrand Beckert; Daniel N Wilson
Journal:  Front Mol Biosci       Date:  2018-05-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.